Formula (Fenofibrate Tablets Usp 48mg And 145mg 1)
Fenofibrate Tablet
Product Images NDC 69238-1260
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fenofibrate (NDC 69238-1260). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
48 mg (Fenofibrate Tablets Usp 48mg And 145mg 2)
This is a description of Fenofibrate tablets, USP. The tablets come in a bottle with a seal that should not be accepted if broken or missing. Each tablet contains 48 mg of fenofibrate, USP. The package insert should be consulted for full prescribing information. The tablets should be stored between 20° to 25°C (68° to 77°F), with excursions permitted between 15" to 30°C (59° to 86°F). The tablets must be dispensed in a tight container as defined in the USP and protected from moisture, and kept out of the reach of children. The product is distributed by Amneal Pharmaceuticals LLC, Bridgewater, 08807.*
145 mg (Fenofibrate Tablets Usp 48mg And 145mg 3)
This is a bottle of Fenofibrate Tablets, USP with each film-coated tablet containing 145mg of fenofibrate, USP. It is advised not to accept if the seal over the bottle opening is broken or missing. The dosage information can be found in the package insert for full prescribing information. The tablets should be stored at 20 to 25°C, with excursions permitted between 15 to 30°C. It should be protected from moisture and kept out of the reach of children. It is distributed by Amneal Pharmaceuticals LLC located in Bridgewater, NJ. The revision was made on June 2016.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
